5 EASY FACTS ABOUT HEMGENIX DESCRIBED

Range of suitable people: CDEC discussed the uncertainty in the number of patients with moderately extreme to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some individuals who are classified as having moderate or reasonable ailment could possibly have a signific